How do I choose between different genetic diagnostic providers for diagnostic accuracy and report clarity?

Choosing between genetic diagnostic providers is mostly about two things: how well they detect the right variants and how clearly they explain the result. A good provider is not necessarily the one with the biggest panel or the flashiest marketing—it’s the one that matches your clinical question and gives an interpretable report.

1) Start with the clinical question

Ask: What are we trying to find?

• Single-gene disorder suspected: You may want targeted sequencing, deletion/duplication analysis, or full gene analysis.
• Known familial variant: Make sure the lab can do targeted variant testing and confirm the exact change.
• Broad, nonspecific symptoms: A panel or exome/genome may be more appropriate.
• Cancer predisposition / reproductive / pharmacogenomics / newborn diagnosis: These each have different performance needs and reporting standards.

A provider can be “good” overall but not the best fit for your specific scenario.

2) Compare analytic validity: can they detect the right things?

Look for whether the provider clearly states:

• What technology is used: sequencing, microarray, MLPA, CNV calling, long-read, etc.
• What variant types are covered:
  • SNVs/small indels
  • copy-number variants
  • repeat expansions
  • structural variants
  • mitochondrial variants
  • low-level mosaicism
  • regions with poor coverage or pseudogenes
• Detection limits and blind spots
  • minimum variant allele fraction for mosaicism
  • coverage thresholds
  • difficult genes/regions
  • inability to detect certain intronic or structural changes

A transparent lab will say where its test is strong and where it is weak.

3) Check validation and quality metrics

Good providers usually provide or can explain:

• Accreditation/quality standards: e.g. CLIA, CAP, ISO, equivalent local accreditation
• Method validation
• Coverage statistics
  • percentage of target bases at ≥20x or similar
  • regions with low/no coverage
• Reproducibility
• False positive/false negative handling
• Confirmatory testing policy
  • whether important findings are confirmed by Sanger, qPCR, MLPA, etc.

If these details are hard to get, that’s a caution sign.

4) Evaluate report clarity

A strong report should answer, in plain language:

• What was tested
• What was found
• What it means clinically
• How confident the lab is
• What was not assessed
• Recommended next steps

Look for reports that include:

• Clear variant nomenclature using standard HGVS format
• Classification: pathogenic, likely pathogenic, VUS, likely benign, benign
• Evidence summary for the classification
• Gene-disease association relevance
• Interpretation in the context of the patient’s phenotype
• Limitations section written in understandable terms
• References to guidelines used for classification

If the report is technically correct but hard to interpret, it may be less useful for diagnosis.

5) Consider how they handle uncertain results

The quality of reporting uncertain findings matters a lot.

Ask:

• Do they report VUS consistently?
• Do they explain what a VUS does and does not mean?
• Do they provide reanalysis or reinterpretation over time?
• Do they offer segregation testing or family studies to help clarify a variant?

A provider that over-reports uncertain findings without good explanation can create confusion.

6) Ask about turnaround time and support

For diagnostic accuracy and clarity, service matters too:

• Turnaround time
• Access to a genetic counselor or lab director
• Ability to discuss a case before ordering
• Post-report consultation
• Mechanism for reclassification updates

The best labs are often willing to talk through unusual cases.

7) Compare a few practical provider questions

You can ask each provider:

1. What exact variant types does this test detect?
2. What are the known limitations for this gene/test?
3. What is the typical coverage in the genes of interest?
4. How do you classify and report VUS?
5. Do you confirm clinically significant variants with another method?
6. Do you provide a concise clinical interpretation in the report?
7. Can you share a sample report?
8. Do you support reanalysis or reinterpretation?
9. Are you accredited and how is your quality monitored?
10. How do you handle incidental or secondary findings, if relevant?

8) Red flags

Be cautious if a provider:

• Uses vague marketing language instead of specific methods
• Won’t state detection limits or coverage
• Doesn’t clearly separate pathogenic findings from VUS
• Gives overly definitive claims like “rules out the disorder”
• Has no clear limitations section
• Produces reports that are too long, too vague, or too technical without interpretation
• Offers no access to lab support for complex cases

9) A simple decision rule

Choose the provider that best meets all three:

1. Appropriate test for the clinical question
2. Transparent performance and limitations
3. Clear, clinically useful reporting

If two providers are similar technically, prefer the one with:

• better phenotype-specific interpretation,
• clearer reports,
• stronger support for clinician discussion,
• and better follow-up/reanalysis.

10) Best next step

If you want, I can help you build a comparison checklist you can use to evaluate labs side by side, or help you compare two specific providers if you share their test descriptions/reports.